Overall, our results indicate that NFKB might have a crucial role as a central regulator of the transcriptional network in MDD, at the level of integration of neuroinflammatory, metabolic and synaptic signals, postulating as a possible candidate biomarker for MDD. The gene discussed is NFKB1; the disease is major depressive disorder.